Diagnosis (ICD-10-Code) | Measurement instruments |
---|---|
Migraine/headache (G43/ R51) | |
 | Days with headache (last 4 weeks) [13] |
 | Scale range from 0 to 28 days |
Allergic rhinitis (J30) | |
 | Standardised Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ(S)) [14] [for participants aged ≥18 years] |
 | Adolescent Rhinoconjunctivitis Quality of Life Questionnaire (AdolRQLQ) [17] [for participants aged 12–17 years] |
 | Scale range from not impaired at all [0 points] to severely impaired [6 points] Minimal clinical important difference for both questionnaires: ±0.5 points |
Asthma (J45) | |
 | Standardised Asthma Quality of Life Questionnaire (AQLQ(S)) [15] [for participants aged ≥17 years] |
 | Paediatric Asthma Quality of Life Questionnaire – Standardised version (PAQLQ) [16] [for participants aged 12–16 years] |
 | Scale range from not impaired at all [1 point] to severely impaired [7 points] Minimal clinical important difference for both questionnaires: ±0.5 points |
Atopic dermatitis (L20) | |
 | Dermatology Life Quality Index (DLQI) [18] [for participants aged ≥17 years] |
 | Children Dermatology Life Quality Index (CDLQI) [19] [for participants aged 12–16 years] |
 | Scale range from no effect on patient’s life [0 points] to extremely large effect on patient’s life [30 points] Minimal clinical important difference: ±4 points |
Depression (F32) | |
 | |
 | Scale range from minimal depression symptoms [0 points] to severe depression symptoms [63 points] Minimal clinical important difference: ±5 points |
All participants | |
 | 12-Item Short Form Health Survey Version 1 (SF-12) [22] |
 | Online Screening questionnaire (for checking inclusion end exclusion criteria) |